GNRSU stock falls to $1.00e-06 on 04 Feb 2026 PNK: top loser signals ahead

GNRSU stock sank intraday to $1.00e-06 (USD) on 04 Feb 2026 during market hours, marking a -99.99% move from the prior close of $0.15. Traders noted thin volume at 145.00 shares and a tiny market cap near $13.00, placing Greenrose Holding Company Inc. (GNRSU) among the session’s top losers on the PNK exchange in the United States. This piece breaks down price action, fundamentals, Meyka AI grading, and the forecast outlook for active traders and investors.

GNRSU stock intraday plunge and price action

The most important fact is the price collapse to $1.00e-06 from $0.15 previous close. The one-day change registers approximately -99.9993%, driven by an extremely low traded volume of 145.00 shares and a tiny visible float.

Market participants typically see this pattern as liquidity-driven selling rather than fresh fundamental news. The PNK listing and sparse trading amplify volatility; the quoted day low and high were both $1.00e-06, showing a near halt in meaningful bid depth.

Fundamental snapshot and valuation metrics for GNRSU stock

Greenrose Holding Company Inc. operates in Healthcare, specifically Drug Manufacturers – Specialty & Generic, and is headquartered in Amityville, NY. Key published figures include EPS 3.10, previous close $0.15, shares outstanding 12853627.00, and reported book value per share 4.30.

Conventional valuation ratios are distorted by the micro price. Reported PE and PB metrics compute to near-zero denominators; treat them as unreliable in this intraday context. The company shows operating cash flow per share 0.51 and free cash flow per share 0.16, which indicate operating earnings despite the tiny market price.

Trading context, liquidity and sector comparison for GNRSU stock

Volume remains the central concern: 145.00 shares traded versus no published average volume, creating large bid-ask gaps. The Healthcare sector saw modest moves today, but GNRSU’s drop is isolated and liquidity-driven. Drug Manufacturers – Specialty & Generic peers trade with far higher volumes and deeper order books, underscoring GNRSU’s microcap fragility.

Low current ratio 0.21 and debt-to-equity 1.57 raise solvency flags if trading remains illiquid. Inventory days are long at 439.24, which suggests operational challenges versus peers.

Meyka AI grade and model forecast for GNRSU stock

Meyka AI rates GNRSU with a score out of 100: 63.07 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Meyka AI’s forecast model projects a year‑ahead value of $0.00, reflecting model inputs and current market illiquidity. Compared with the current price $1.00e-06, the model implies roughly -100.00% downside to a zero price target. Forecasts are model-based projections and not guarantees.

Risks, catalysts and short-term outlook for GNRSU stock

Immediate risks include continued low liquidity, potential delisting pressure on PNK, and inventory turnover inefficiencies. A lack of recent earnings announcements and thin public float raises the probability of wide intraday swings. Positive catalysts would be clear operational updates, regulatory clarity for cannabis operations, or renewed institutional interest.

Traders should watch for regulatory filings, management commentary from CEO Nicole Conboy, and volume spikes that could restore price discovery. Use strict size limits and stop rules due to microcap volatility.

Price targets, scenario planning and GNRSU stock strategy

No broker consensus price target is available. For scenario planning, consider: downside case $0.00 if liquidity collapses; base case $0.02 if operations stabilize and trading improves; and a bull case $0.15 if renewed investor interest returns to prior levels. These are analyst-style scenarios, not recommendations.

Given the PNK listing and low market cap $13.00, allocators should treat GNRSU as speculative and size positions accordingly. For deeper company data see the company site and market overview on OTC Markets GNRSU page. Internal coverage and historic trades are available on the Meyka stock page: Meyka GNRSU.

Final Thoughts

GNRSU stock is a top loser in the PNK session on 04 Feb 2026, trading at $1.00e-06 on very light volume of 145.00 shares and a market cap near $13.00. The intraday collapse reflects severe liquidity constraints rather than clear new public fundamentals. Meyka AI rates GNRSU 63.07 (B, HOLD) after weighing benchmark and sector comparisons, key metrics, and forecast inputs. Meyka AI’s forecast model projects $0.00 for the year ahead, implying roughly -100.00% versus the current quote; forecasts are model-based projections and not guarantees. Practical takeaways: only experienced traders with strict risk controls should trade GNRSU, and long-term investors should wait for clearer financial reports or improved trading depth. Monitor filings, management updates, and volume recovery as primary signals before adjusting position sizing.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.